Ruthenium Fd SA SIF - Global Pharma Fund R USD Acc Fonds
|  | 
ISIN: LU2234857741
Nettoinventarwert (NAV)
| 115,23 USD | USD | % | 
|---|
| Vortag | USD | Datum | 30.09.2025 | 
Anlagepolitik
			So investiert der Ruthenium Fd SA SIF - Global Pharma Fund R USD Acc Fonds: The investment objective of the Sub-Fund is to generate long-term returns consistent with the preservation of capital and prudent investment management. The objective is pursued through a strategy focused on investments in the global healthcare, pharmaceutical and biotechnology sectors or industries. The Sub-Fund will mainly invest in exchange-traded and OTC equity-linked derivatives including but not limited to options, warrants and structured notes. The Sub-Fund may also invest in equities.
		
	Ruthenium Fd SA SIF - Global Pharma Fund R USD Acc Fonds aktueller Kurs
| 108,89 USD | 3,89 USD | 3,70 % | 
|---|
| Datum | 31.07.2025 | 
| Vortag | 108,89 USD | 
| Börse | FII | 
Rating für Ruthenium Fd SA SIF - Global Pharma Fund R USD Acc Fonds
| €uro FondsNote | - | 
Fonds Performance: Ruthenium Fd SA SIF - Global Pharma Fund R USD Acc Fonds
| Performance 1 Jahr | -11,74 | |
| Performance 2 Jahre | -17,02 | |
| Performance 3 Jahre | -10,07 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - | 
Fundamentaldaten
| WKN | |
| ISIN | LU2234857741 | 
| Name | Ruthenium Fd SA SIF - Global Pharma Fund R USD Acc Fonds | 
| Fondsgesellschaft | Funds Avenue | 
| Aufgelegt in | Luxembourg | 
| Auflagedatum | 30.09.2020 | 
| Kategorie | Branchen: Gesundheitswesen | 
| Währung | USD | 
| Volumen | 47 501 156,96 | 
| Depotbank | CACEIS Bank, Luxembourg Branch | 
| Zahlstelle | |
| Fondsmanager | |
| Geschäftsjahresende | 31.12. | 
| Berichtsstand | 06.10.2025 | 
Konditionen
| Ausgabeaufschlag | % | 
| Verwaltungsgebühr | % | 
| Depotbankgebühr | % | 
| VL-fähig? | Nein | 
| Mindestanlage | |
| Ausschüttung | Thesaurierend | 
 
									 
									 
								